Sterizar Limited Filleted Accounts Cover
Sterizar Limited
Company No. 05986391
Unaudited Accounts
31 December 2024
Sterizar Limited Directors Report Registrar
The Directors present their report and accounts for the year ended 31 December 2024.
Principal activities
The principal activity of the company during the year under review was the sale of pharmaceutical goods.
Directors
The Directors who served during the year were as follows:
P. Howard
N.P. Oakes
W.A. Thompson
The above report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime as set out in Part 15 of the Companies Act 2006.
Signed on behalf of the board
........................................................................................................
N.P. Oakes
Director
29 August 2025
Sterizar Limited Balance Sheet Registrar
at
31 December 2024
Company No.
05986391
2024
2023
£
£
Fixed assets
1,2351,544
Current assets
121,79968,471
Creditors: Amounts falling due within one year
(47,598)
(28,852)
Net current assets
74,20139,619
Total assets less current liabilities
75,43641,163
Accruals and deferred income
(1,244)
(994)
74,19240,169
Capital and reserves
74,192
40,169
NOTES TO THE ACCOUNTS
1
Basis of preparation
These accounts have been prepared in accordance with the micro-entity provisions of the small companies regime.
2
Employees
2024
2023
Number
Number
The average monthly number of employees (including directors) during the year was:
3
3
3
General information
Sterizar Limited is a private company limited by shares and incorporated in England and Wales.
Its registered number is:
05986391
Its registered office is:
Its trading address is:
Suite 11, The Old Fuel Depot
Malvern Suite, Earl Mill
Twemlow Lane
Dowry Street
Twemlow
Oldham
Cheshire
Lancashire
CW4 8GJ
OL8 2PF
For the year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
As permitted by section 444 (5A) of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.
The accounts were approved by the board of directors on 29 August 2025 and signed on its behalf by:
N.P. Oakes - Director
Sterizar Limited0598639131 December 202401 January 2024false29 August 2025BTCSoftware AP Solution 2025 12.1.0312.1.03The principal activity of the company during the year under review was the sale of pharmaceutical goods. 059863912024-01-012024-12-31059863912024-12-31059863912023-12-3105986391core:WithinOneYear2024-12-3105986391core:WithinOneYear2023-12-31059863912023-01-012023-12-3105986391countries:UnitedKingdom2024-01-012024-12-3105986391bus:RegisteredOffice2024-01-012024-12-31059863912024-01-0105986391bus:Micro-entities2024-01-012024-12-3105986391bus:FullAccounts2024-01-012024-12-3105986391bus:AuditExempt-NoAccountantsReport2024-01-012024-12-3105986391bus:Director22024-01-012024-12-3105986391bus:PrivateLimitedCompanyLtd2024-01-012024-12-31iso4217:GBPxbrli:pure